GameStop Corp. vs Revolution Medicines Inc. Common Stock — how do they compare? GameStop Corp. trades at $26.07 (market cap $12.75B), while Revolution Medicines Inc. Common Stock trades at $191.49 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 3.2× GameStop Corp.'s market cap, and GameStop Corp. is trading nearer its 52-week high, Revolution Medicines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 61 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| GME | RVMD | |
|---|---|---|
Market Cap | $12.75B | $40.32B |
Volume | 13,026,993 | 4,855,734 |
Sector | Consumer Cyclical | Health |
52-Week High | $26.53 | $221.15 |
52-Week Low | $17.87 | $47.50 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $12.03B | $37.02B |
Signals from Pluang's Aura AI — not financial advice
GameStop (GME) trades at $26.37, up 7.28% in 24 hours, with a bullish technical signal and strong insider buying by CEO Ryan Cohen. The company reported net income of $131.3 million in 2025, a significant turnaround from prior losses, though revenue declined to $3.82 billion. Valuation ratios include a P/E of 16.63 and P/S of 4.22, while analyst consensus remains mixed with 16.67% buy ratings.
The outlook hinges on sustained profitability and strategic shifts, but risks include revenue volatility and competitive pressures. Insider confidence provides near-term support, yet the stock faces headwinds from cautious Wall Street sentiment and execution challenges in a declining physical retail environment.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →